| pubmed-article:12134237 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C0369169 | lld:lifeskim |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C1332051 | lld:lifeskim |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
| pubmed-article:12134237 | lifeskim:mentions | umls-concept:C0205344 | lld:lifeskim |
| pubmed-article:12134237 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:12134237 | pubmed:dateCreated | 2002-7-22 | lld:pubmed |
| pubmed-article:12134237 | pubmed:abstractText | To study whether Epstein-Barr virus (EBV) load can be used to predict the occurrence of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma (AIDS-NHL), we determined EBV load longitudinally for individuals infected with human immunodeficiency virus type 1. EBV load in peripheral blood mononuclear cells (PBMC) was high and displayed considerable fluctuations over time, indicating that absolute EBV load in PBMC is not predictive of the development of AIDS-NHL. EBV DNA was also detectable in serum at some time points but at a lower level. | lld:pubmed |
| pubmed-article:12134237 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12134237 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12134237 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12134237 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12134237 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12134237 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12134237 | pubmed:issn | 0022-1899 | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:OsterhausAlbe... | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:MiedemaFrankF | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:NiestersHuber... | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:WolthersKatja... | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:HovenkampEgbe... | lld:pubmed |
| pubmed-article:12134237 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:12134237 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12134237 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:12134237 | pubmed:volume | 186 | lld:pubmed |
| pubmed-article:12134237 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12134237 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12134237 | pubmed:pagination | 405-9 | lld:pubmed |
| pubmed-article:12134237 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:meshHeading | pubmed-meshheading:12134237... | lld:pubmed |
| pubmed-article:12134237 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12134237 | pubmed:articleTitle | Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. | lld:pubmed |
| pubmed-article:12134237 | pubmed:affiliation | Department of Clinical Viro-Immunology, Sanquin Research at CLB, and Department of Hematology, Academic Medical Center, University of Amsterdam, 1066 CX Amsterdam, The Netherlands. D_van_Baarle@clb.nl | lld:pubmed |
| pubmed-article:12134237 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12134237 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12134237 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12134237 | lld:pubmed |
